国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (13): 2226-2231.DOI: 10.3760/cma.j.cn441417-20250122-13023

• 中医药研究 • 上一篇    下一篇

祛痰宣肺汤联合西药治疗小儿毛细支气管炎(痰热闭肺证)的疗效观察

孙媛 叶佳鑫 张国成   

  1. 陕西中医院大学第二附属医院儿科,咸阳 712000

  • 收稿日期:2025-01-22 出版日期:2025-07-01 发布日期:2025-08-04
  • 通讯作者: 叶佳鑫,Email:yjx19930104@163.com
  • 基金资助:

    中医药传承创新暨“秦药”开发重点科学研究项目(2021-01-22-015)

Effect of Qutan Xuanfei decoction combined with western medicine and the effect on airway inflammation on children with bronchiolitis (Phlegm shuts lung card hotly)

Sun Yuan, Ye Jiaxin, Zhang Guocheng   

  1. Department of Pediatrics, Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xianyang 712000, China

  • Received:2025-01-22 Online:2025-07-01 Published:2025-08-04
  • Contact: Ye Jiaxin, Email: yjx19930104@163.com
  • Supported by:

    Key Scientific Research Project on Traditional Chinese Medicine Inheritance and Innovation and Development of "Qin Medicine" (2021-01-22-015)

摘要:

目的 探讨祛痰宣肺汤联合西药治疗小儿毛细支气管炎(痰热闭肺证)的效果。方法 采用前瞻性随机对照试验,选取2023年1月至2024年6月陕西中医院大学第二附属医院收治的96例毛细支气管炎患儿,中医辨证分型均为痰热闭肺证。按照随机数字表法分为两组,各48例。观察组中男29例、女19例,年龄6(3,14)月,病程(2.85±0.57)d,轻度17例、中度31例。对照组中男30例、女18例,年龄6(3,15)月,病程(2.81±0.55)d,轻度15例、中度33例。对照组给予布地奈德+盐酸氨溴索+特布他林+生理盐水雾化吸入,每次10~15 min,每日2次;同时给予对症治疗。观察组在对照组基础上联合祛痰宣肺汤治疗,祛痰宣肺汤根据患儿年龄大小取量,每日3次。两组均持续治疗7 d。比较两组治疗前后中医证候评分、吸气/呼气时间比(Ti/Te)、每千克体重潮气量(VT/kg)、呼吸阻力、气道炎症指标[白细胞介素(IL)-4、IL-8及肿瘤坏死因子-α(TNF-α)],比较两组临床疗效、不良反应发生情况。采用Fisher确切概率法、校正χ2检验、χ2检验、秩和检验、t检验进行统计分析。结果 治疗后,观察组中医证候评分中的主症、次症、舌脉象、总分分别为(3.09±0.62、2.28±0.42、0.72±0.15、6.09±1.21)分,对照组分别为(4.56±0.91、2.93±0.55、1.02±0.18、8.51±1.35)分;观察组Ti/Te、VT/kg水平均高于对照组[0.85±0.18比0.72±0.14、(9.36±1.45)ml/kg比(8.35±1.35)ml/kg],呼吸阻力低于对照组[(3.26±0.62)kPa/(s·L)比(4.47±0.82)kPa/(s·L)];观察组IL-4、IL-8、TNF-α水平分别为(4.03±0.82、28.64±5.41、55.62±10.22)ng/L,对照组为(5.10±1.05、37.94±7.01、71.52±12.74)ng/L;上述指标比较,差异均有统计学意义(均P<0.05)。观察组总有效率为97.83%(45/46),高于对照组的82.22%(37/45)(P=0.015)。两组不良反应总发生率[10.87%(5/46)比6.67%(3/45)]比较,差异无统计学意义(校正χ2=0.114,P=0.736)。结论 祛痰宣肺汤联合西药治疗小儿毛细支气管炎(痰热闭肺证)效果理想,可减轻患儿病情、改善肺功能,控制气道炎症,安全性较高。

关键词: 毛细支气管炎, 痰热闭肺证, 祛痰宣肺汤, 儿童, 气道炎症

Abstract:

Objective To explore the efficacy of Qutan Xuanfei decoction combined with Western medicine in treating pediatric bronchiolitis (Phlegm shuts lung card hotly). Methods A total of 96 children with bronchiolitis, all diagnosed with Phlegm shuts lung card hotly, were selected from the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine between January 2023 and June 2024. The children were randomly divided into two groups, with 48 patients in each group. In the observation group, there were 29 males and 19 females, aged 6 (3, 14) months and the disease duration was (2.85±0.57) d, including 17 mild and 31 moderate cases. In the control group, there were 30 males and 18 females, aged 6 (3, 15) months and the disease duration was (2.81±0.55) d, including 15 mild and 33 moderate cases. The control group received nebulized budesonide + ambroxol hydrochloride + terbutaline + normal saline, administered for 10-15 minutes, twice daily, along with symptomatic treatment. The observation group received Qutan Xuanfei decoction in addition to the treatment given to the control group, with dosages adjusted based on the child's age, administered three times daily. Both groups underwent treatment for 7 days. The study compared traditional Chinese medicine (TCM) syndrome scores, inspiratory/expiratory ratio (Ti/Te), tidal volume per kilogram (VT/kg), respiratory resistance, and airway inflammation indicators [interleukin (IL)-4, IL-8, and tumor necrosis factor-alpha (TNF-α)] before and after treatment, as well as clinical efficacy and adverse reactions between the two groups. Statistical analysis was performed using Fisher's exact probability method, corrected χ² test, χ² test, rank-sum test, and t test. Results After treatment, the scores for primary symptoms, secondary symptoms, tongue and pulse signs, and total scores in the observation group were (3.09±0.62, 2.28±0.42, 0.72±0.15, 6.09±1.21) points, compared to (4.56±0.91, 2.93±0.55, 1.02±0.18, 8.51±1.35) points in the control group. The Ti/Te and VT/kg values in the observation group were higher than those in the control group [0.85±0.18 vs. 0.72±0.14 and (9.36±1.45) ml/kg vs. (8.35±1.35) ml/kg], while the respiratory resistance was lower in the observation group [(3.26±0.62) kPa/(s·L) vs. (4.47±0.82) kPa/(s·L)]. The levels of IL-4, IL-8, and TNF-α in the observation group were (4.03±0.82, 28.64±5.41, 55.62±10.22) ng/L, compared to (5.10±1.05, 37.94±7.01, 71.52±12.74) ng/L in the control group; all differences were statistically significant (all P<0.05). The overall effective rate in the observation group was 97.83% (45/46), higher than the 82.22% (37/45) in the control group (P=0.015). The total incidence of adverse reactions in both groups was [10.87% (5/46) vs. 6.67% (3/45)], with no statistically significant difference (corrected χ²=0.114, P=0.736). Conclusion The therapeutic effect of Qutan Xuanfei decoction combined with western medicine in the treatment of children with bronchiolitis (Phlegm shuts lung card hotly) is ideal and it is safety.

Key words: Bronchiolitis,  , Phlegm shuts lung card hotly,  , Qutan Xuanfei , decoction,  , Children,  , Airway inflammation